Loading…

Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2023)

Hyperglycemia significantly contributes to complications in patients with diabetes mellitus. While lifestyle interventions remain cornerstones of disease prevention and treatment, most patients with type 2 diabetes will eventually require pharmacotherapy for glycemic control. The definition of indiv...

Full description

Saved in:
Bibliographic Details
Published in:Wiener Klinische Wochenschrift 2023-01, Vol.135 (Suppl 1), p.32
Main Authors: Clodi, Martin, Abrahamian, Heidemarie, Brath, Helmut, Schernthaner, Guntram, Brix, Johann, Ludvik, Bernhard, Drexel, Heinz, Saely, Christoph H, Fasching, Peter, Rega-Kaun, Gersina, Föger, Bernhard, Francesconi, Claudia, Fröhlich-Reiterer, Elke, Kautzky-Willer, Alexandra, Harreiter, Jürgen, Luger, Anton, Resl, Michael, Riedl, Michaela, Winhofer, Yvonne, Hofer, Sabine E, Hoppichler, Friedrich, Huber, Joakim, Kaser, Susanne, Ress, Claudia, Lechleitner, Monika, Aberer, Felix, Mader, Julia K, Sourij, Harald, Toplak, Hermann, Paulweber, Bernhard, Stechemesser, Lars, Pieber, Thomas, Prager, Rudolf, Stingl, Harald, Stulnig, Thomas, Rami-Merhar, Birgit, Roden, Michael, Schelkshorn, Christian, Wascher, Thomas C, Weitgasser, Raimund, Zlamal-Fortunat, Sandra
Format: Article
Language:ger
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hyperglycemia significantly contributes to complications in patients with diabetes mellitus. While lifestyle interventions remain cornerstones of disease prevention and treatment, most patients with type 2 diabetes will eventually require pharmacotherapy for glycemic control. The definition of individual targets regarding optimal therapeutic efficacy and safety as well as cardiovascular effects is of great importance. In this guideline we present the most current evidence-based best clinical practice data for healthcare professionals.
ISSN:1613-7671
1613-7671
DOI:10.1007/s00508-023-02186-4